Literature DB >> 18228140

The use of cognitive behavioral therapy in the treatment of depression for individuals with CHF.

Erin O'Hea1, Joshua Houseman, Kristyna Bedek, Rosanna Sposato.   

Abstract

Patients diagnosed with CHF have disproportionately high rates of depression. Research has demonstrated significant consequences of depression in patients with CHF including poor quality of life, worse medical adherence and increased health complications, health care utilization, and medical costs. Despite these consequences, the treatment of depression in patients with CHF has not been widely explored. In fact, a review of the literature demonstrates a clear gap when it comes to efficacious treatments of depression in patients afflicted with CHF. The present article introduces the empirically supported therapy 'cognitive behavioral therapy' (CBT) and provides information about the literature supporting the use of CBT in depressed patients. Finally, the present authors offer some practical suggestions for healthcare providers treating depressed patients with CHF.

Entities:  

Mesh:

Year:  2008        PMID: 18228140     DOI: 10.1007/s10741-008-9081-2

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  39 in total

1.  Cognitive therapy and pharmacotherapy for depression. Singly and in combination.

Authors:  S D Hollon; R J DeRubeis; M D Evans; M J Wiemer; M J Garvey; W M Grove; V B Tuason
Journal:  Arch Gen Psychiatry       Date:  1992-10

2.  THINKING AND DEPRESSION. II. THEORY AND THERAPY.

Authors:  A T BECK
Journal:  Arch Gen Psychiatry       Date:  1964-06

3.  Silver linings and candles in the dark: differences among positive coping strategies in predicting subjective well-being.

Authors:  Michelle N Shiota
Journal:  Emotion       Date:  2006-05

4.  Coping success and its relationship to psychological distress for older adults.

Authors:  A J Zautra; A B Wrabetz
Journal:  J Pers Soc Psychol       Date:  1991-11

5.  A meta-analysis of the effects of cognitive therapy in depressed patients.

Authors:  V Gloaguen; J Cottraux; M Cucherat; I M Blackburn
Journal:  J Affect Disord       Date:  1998-04       Impact factor: 4.839

6.  Dynamics of a stressful encounter: cognitive appraisal, coping, and encounter outcomes.

Authors:  S Folkman; R S Lazarus; C Dunkel-Schetter; A DeLongis; R J Gruen
Journal:  J Pers Soc Psychol       Date:  1986-05

7.  Cognitive-behavioral and psychodynamic group psychotherapy in treatment of geriatric depression.

Authors:  J L Steuer; J Mintz; C L Hammen; M A Hill; L F Jarvik; T McCarley; P Motoike; R Rosen
Journal:  J Consult Clin Psychol       Date:  1984-04

8.  The effect of exercise on depressive symptoms in the moderately depressed elderly.

Authors:  J K McNeil; E M LeBlanc; M Joyner
Journal:  Psychol Aging       Date:  1991-09

9.  The association between disease severity, functional status, depression and daily quality of life in congestive heart failure patients.

Authors:  Robert A Carels
Journal:  Qual Life Res       Date:  2004-02       Impact factor: 4.147

10.  Functional status, mood disturbance and quality of life in patients with heart failure.

Authors:  M H Hawthorne; M E Hixon
Journal:  Prog Cardiovasc Nurs       Date:  1994
View more
  3 in total

Review 1.  A Systematic Review of Relaxation, Meditation, and Guided Imagery Strategies for Symptom Management in Heart Failure.

Authors:  Kristine L Kwekkeboom; Lisa C Bratzke
Journal:  J Cardiovasc Nurs       Date:  2016 Sep-Oct       Impact factor: 2.083

2.  Barriers and facilitators influencing self-management among COPD patients: a mixed methods exploration in primary and affiliated specialist care.

Authors:  Chantal F Hillebregt; Auke J Vlonk; Marc A Bruijnzeels; Onno Cp van Schayck; Niels H Chavannes
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-12-23

3.  The real world mental health needs of heart failure patients are not reflected by the depression randomized controlled trial evidence.

Authors:  Phillip J Tully; Gary Wittert; Terina Selkow; Harald Baumeister
Journal:  PLoS One       Date:  2014-01-24       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.